142 related articles for article (PubMed ID: 37252294)
21. Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study.
Costain D; Elder G; Fraser B; Slagel B; Kelly A; Cheong Y; Fera L
Can J Surg; 2021 Aug; 64(4):E449-E456. PubMed ID: 34388107
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of intravenous tranexamic acid administration at induction in definitive hip fracture surgery: Is there a role?
Kanthasamy S; Guhan B; Chakravarty D; Parker MJ
Injury; 2021 Aug; 52(8):2361-2366. PubMed ID: 33568279
[TBL] [Abstract][Full Text] [Related]
23. Safety and Efficacy of Tranexamic Acid in Hip Hemiarthroplasty for Fracture Neck Femur: a Systematic Review and Meta-analysis.
Tripathy SK; Varghese P; Kumarasamy AKN; Mishra NP; Neradi D; Jain M; Sarkar S; Sen RK
Indian J Orthop; 2023 Jan; 57(1):33-43. PubMed ID: 36660490
[TBL] [Abstract][Full Text] [Related]
24. Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial.
Nikolaou VS; Masouros P; Floros T; Chronopoulos E; Skertsou M; Babis GC
Bone Joint J; 2021 Mar; 103-B(3):442-448. PubMed ID: 33641430
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy and safety of intravenous combined with topical administration of tranexamic acid in reducing blood loss after intramedullary fixation of intertrochanteric femoral fractures].
Li H; Liu D; Tang X; Wang N; Gong D; Wu Y; Zhang Y; Li W; Gou Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2021 May; 35(5):550-555. PubMed ID: 33998206
[TBL] [Abstract][Full Text] [Related]
26. High-dose (3 g) topical tranexamic acid has higher potency in reducing blood loss after total knee arthroplasty compared with low dose (500 mg): a double-blind randomized controlled trial.
Tammachote N; Raphiphan R; Kanitnate S
Eur J Orthop Surg Traumatol; 2019 Dec; 29(8):1729-1735. PubMed ID: 31359178
[TBL] [Abstract][Full Text] [Related]
27. Use of tranexamic acid is not associated with complications following bipolar hemiarthroplasty for metastatic disease.
Owen A; Wellings EP; Wyles CC; Yuan BJ; Rose PS; Houdek MT
J Surg Oncol; 2021 Mar; 123(4):1121-1125. PubMed ID: 33368348
[TBL] [Abstract][Full Text] [Related]
28. The Efficacy and Safety of Combination of Intravenous and Topical Tranexamic Acid in Revision Hip Arthroplasty: A Randomized, Controlled Trial.
Wu YG; Zeng Y; Yang TM; Si HB; Cao F; Shen B
J Arthroplasty; 2016 Nov; 31(11):2548-2553. PubMed ID: 27179770
[TBL] [Abstract][Full Text] [Related]
29. Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.
Sun Q; Li J; Chen J; Zheng C; Liu C; Jia Y
BMJ Open; 2019 Jan; 9(1):e024350. PubMed ID: 30696680
[TBL] [Abstract][Full Text] [Related]
30. Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis.
Shin YS; Yoon JR; Lee HN; Park SH; Lee DH
Knee Surg Sports Traumatol Arthrosc; 2017 Nov; 25(11):3585-3595. PubMed ID: 27417102
[TBL] [Abstract][Full Text] [Related]
31. Optimal dose of topical tranexamic acid considering efficacy and safety in total knee arthroplasty: a randomized controlled study.
Kim JK; Park JY; Lee DY; Ro DH; Han HS; Lee MC
Knee Surg Sports Traumatol Arthrosc; 2021 Oct; 29(10):3409-3417. PubMed ID: 32869124
[TBL] [Abstract][Full Text] [Related]
32. Intravenous Versus Topical Tranexamic Acid in Total Knee Arthroplasty: Both Effective in a Randomized Clinical Trial of 640 Patients.
Abdel MP; Chalmers BP; Taunton MJ; Pagnano MW; Trousdale RT; Sierra RJ; Lee YY; Boettner F; Su EP; Haas SB; Figgie MP; Mayman DJ
J Bone Joint Surg Am; 2018 Jun; 100(12):1023-1029. PubMed ID: 29916929
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of Efficacy of Systemic Administration of Tranexamic Acid (Exacyl) in Total Hip and Knee Arthroplasty - Prospective Cohort Study].
Mannová J; Kubát P; Pospíchal M; Longin P
Acta Chir Orthop Traumatol Cech; 2019; 86(2):118-123. PubMed ID: 31070570
[TBL] [Abstract][Full Text] [Related]
34. Neer Award 2015: A randomized, prospective evaluation on the effectiveness of tranexamic acid in reducing blood loss after total shoulder arthroplasty.
Gillespie R; Shishani Y; Joseph S; Streit JJ; Gobezie R
J Shoulder Elbow Surg; 2015 Nov; 24(11):1679-84. PubMed ID: 26480877
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial.
Zhou XD; Zhang Y; Jiang LF; Zhang JJ; Zhou D; Wu LD; Huang Y; Xu NW
Orthop Surg; 2019 Aug; 11(4):635-642. PubMed ID: 31419080
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Intravenous and Topical Tranexamic Acid in Total Joint Arthroplasty.
Masaryk J; Melus V; Vidan J; Steno B
Acta Chir Orthop Traumatol Cech; 2022; 89(4):286-292. PubMed ID: 36055669
[TBL] [Abstract][Full Text] [Related]
37. [Effect of tranexamic acid on blood loss and soft-tissue swelling following cemented total hip replacement].
Gombár C; Gálity H; Bácsi M; Sisák K
Orv Hetil; 2019 Mar; 160(12):456-463. PubMed ID: 30876382
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of tranexamic acid in acute hip hemiarthroplasties in frail geriatric patients.
van Rijckevorsel VAJIM; Roukema GR; Kuijper TM; de Jong L
Orthop Traumatol Surg Res; 2022 Sep; 108(5):103219. PubMed ID: 35093562
[TBL] [Abstract][Full Text] [Related]
39. Comparison of 3 Routes of Administration of Tranexamic Acid on Primary Unilateral Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
Yuan X; Li B; Wang Q; Zhang X
J Arthroplasty; 2017 Sep; 32(9):2738-2743. PubMed ID: 28455182
[TBL] [Abstract][Full Text] [Related]
40. Is topical or intravenous tranexamic acid preferred in total hip arthroplasty? A randomized, controlled, noninferiority clinical trial.
Zhou KD; Wang HY; Wang Y; Liu ZH; He C; Feng JM
PLoS One; 2018; 13(10):e0204551. PubMed ID: 30278067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
